EP0619836A4 - Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments. - Google Patents

Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments.

Info

Publication number
EP0619836A4
EP0619836A4 EP93900825A EP93900825A EP0619836A4 EP 0619836 A4 EP0619836 A4 EP 0619836A4 EP 93900825 A EP93900825 A EP 93900825A EP 93900825 A EP93900825 A EP 93900825A EP 0619836 A4 EP0619836 A4 EP 0619836A4
Authority
EP
European Patent Office
Prior art keywords
type
production
methods
growth factor
factor receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93900825A
Other languages
English (en)
Other versions
EP0619836A1 (en
Inventor
David Wolf
James E Tomlinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COR Therapeutics Inc
Original Assignee
COR Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COR Therapeutics Inc filed Critical COR Therapeutics Inc
Publication of EP0619836A1 publication Critical patent/EP0619836A1/en
Publication of EP0619836A4 publication Critical patent/EP0619836A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP93900825A 1991-12-02 1992-12-01 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments. Withdrawn EP0619836A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80179491A 1991-12-02 1991-12-02
US801794 1991-12-02
PCT/US1992/010430 WO1993011223A1 (en) 1991-12-02 1992-12-01 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments

Publications (2)

Publication Number Publication Date
EP0619836A1 EP0619836A1 (en) 1994-10-19
EP0619836A4 true EP0619836A4 (en) 1996-12-04

Family

ID=25182041

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93900825A Withdrawn EP0619836A4 (en) 1991-12-02 1992-12-01 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments.

Country Status (9)

Country Link
EP (1) EP0619836A4 (ja)
JP (1) JPH07501702A (ja)
AU (1) AU675924B2 (ja)
CA (1) CA2124957A1 (ja)
NO (1) NO942032L (ja)
NZ (1) NZ246256A (ja)
PL (1) PL171788B1 (ja)
RU (1) RU94046397A (ja)
WO (1) WO1993011223A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468468A (en) * 1989-02-09 1995-11-21 The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services Method for making a monoclonal antibody, monoclonal antibodies to α PD
US7252929B2 (en) 1989-02-09 2007-08-07 United States Of America, As Represented By The Secretary, Dept Of Health & Human Services Methods for identifying alpha PDGFR agonists and antagonists
US6228600B1 (en) 1992-07-20 2001-05-08 The United States Of America As Represented By The Department Of Health And Human Services Immunoassays for the alpha platelet-derived growth factor receptor
ES2147729T3 (es) * 1991-01-31 2000-10-01 Cor Therapeutics Inc Dominios de la region extracelular de polipeptidos receptores de factor de crecimiento derivado de plaquetas humano.
US5817310A (en) * 1991-12-02 1998-10-06 Cor Therapeutics, Inc. Inhibitory immunoglobulin polypeptides to human PDGF beta receptor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0325224A2 (en) * 1988-01-22 1989-07-26 ZymoGenetics, Inc. Methods of producing secreted receptor analogs and biologically active peptide dimers.
WO1992013867A1 (en) * 1991-01-31 1992-08-20 Cor Therapeutics, Inc. Domains of extracellular region of human platelet derived growth factor receptor polypeptides
WO1992013870A1 (en) * 1991-01-31 1992-08-20 The Regents Of The University Of California Human platelet-derived growth factor receptors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339356C (en) * 1988-02-02 1997-08-26 Lewis T. Williams Human platelet-derived growth factor receptor
AU2899489A (en) * 1988-02-05 1989-08-10 Guardian Technologies, Inc. Apparatus for delivering a breath sample to a solid state sensor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0325224A2 (en) * 1988-01-22 1989-07-26 ZymoGenetics, Inc. Methods of producing secreted receptor analogs and biologically active peptide dimers.
WO1992013867A1 (en) * 1991-01-31 1992-08-20 Cor Therapeutics, Inc. Domains of extracellular region of human platelet derived growth factor receptor polypeptides
WO1992013870A1 (en) * 1991-01-31 1992-08-20 The Regents Of The University Of California Human platelet-derived growth factor receptors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9311223A1 *

Also Published As

Publication number Publication date
NO942032D0 (no) 1994-06-01
JPH07501702A (ja) 1995-02-23
NO942032L (no) 1994-06-01
AU675924B2 (en) 1997-02-27
EP0619836A1 (en) 1994-10-19
AU3236493A (en) 1993-06-28
CA2124957A1 (en) 1993-06-10
PL171788B1 (pl) 1997-06-30
NZ246256A (en) 1996-01-26
WO1993011223A1 (en) 1993-06-10
RU94046397A (ru) 1996-10-10

Similar Documents

Publication Publication Date Title
GB2222954B (en) Tubular implant and process for the production thereof
EP0510668A3 (en) Phenothiazine derivatives, their production and use
AU2455092A (en) Method of preparing sunscreens
AU2898989A (en) Human platelet-derived growth factor receptor
AU636265B2 (en) Vascular prostheses and method for production thereof
AU2843592A (en) 3,9-diphosphaspiroundecanes and process for making 3,9-diphosphaspiroundecanes
AU626726B2 (en) Uracil derivatives, and their production and use
HU914060D0 (en) Medical preparation and process for its production
HU913137D0 (en) 2-amino-4-carboxamido-pirimidine derivatives, their production and medical use
GR3015662T3 (en) Crystalline human proinsulin and process for its production.
AU646173B2 (en) 3-deoxy-mannosamine derivatives and process for their preparation
AU1447792A (en) Feed and process for production thereof
HU9302727D0 (en) Piperidine derivatives, process for producing them and their therapeutical use
AU3003892A (en) 1-cyanomethyl-4-carboxymethyl-2-ketopiperazine, salts thereof, and process for their preparation
AU3644489A (en) Novel pigments, process for their production and their use
EP0619836A4 (en) Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments.
IL95692A0 (en) Natural delta-lactones and process for their production
HU9302718D0 (en) New 2-spirocyclopropyl-cephalosporin-sulfone derivatives and process for their production
AU6046294A (en) Process for producing human growth hormone
AU4817490A (en) 2',3'-dideoxyribofuranosides and process for producing them
IL100537A0 (en) A process for the preparation of n-alkyl-3,4-dialkyloxyanilines and derivatives thereof
HU9201733D0 (en) New elsamycin derivatives and process for their production
AU2743092A (en) Novel alkaloids and processes for their production
HU9201732D0 (en) New elsamycin derivatives and process for their production
HU9201734D0 (en) New elsamycin derivatives and process for their production

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940603

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19961021

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19981116

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990629